We seek to inform New Zealanders of growing international concerns about the use of puberty blockers for gender-questioning children and adolescents.
Jun 6, 2022 • 9 tweets • 4 min read
There are now 4 systematic evidence reviews of medical interventions for gender dysphoric adolescents published by national/state level medical authorities: UK, Finland, Sweden, Florida.
In all 4, an evidence-based-medicine approach has led to a restriction or outright ban 🧵1/
Thread on the #keirabell judgement and sorry state of evidence-lead health policy in New Zealand.
We have further confirmation that there is no good evidence of benefit from puberty blockers, and significant risks.
1/11
The judges heard evidence for and against, and testimony from former patients. They ruled that puberty blocking is "experimental", with "very limited evidence as to its efficacy"
An unsurprising finding if you're familiar with the literature.
